Lovelace Biomedical Research Institute, Albuquerque, NM, USA.
University of New Mexico School of Medicine, Departments of Neurology and Neurosurgery, Albuquerque, NM, USA.
Adv Exp Med Biol. 2021;1269:283-288. doi: 10.1007/978-3-030-48238-1_45.
Hemorrhagic shock (HS) is a severe complication of traumatic brain injury (TBI) that doubles mortality due to severely compromised microvascular cerebral blood flow (mvCBF) and oxygen delivery reduction, as a result of hypotension. Volume expansion with resuscitation fluids (RF) for HS does not improve microvascular CBF (mvCBF); moreover, it aggravates brain edema. We showed that the addition of drag-reducing polymers (DRP) to crystalloid RF (lactated Ringer's) significantly improves mvCBF, oxygen supply, and neuronal survival in rats suffering TBI+HS. Here, we compared the effects of colloid RF (Hetastarch) with DRP (HES-DRP) and without (HES). Fluid percussion TBI (1.5 ATA, 50 ms) was induced in rats and followed by controlled HS to a mean arterial pressure (MAP) of 40 mmHg. HES or HES-DRP was infused to restore MAP to 60 mmHg for 1 h (prehospital period), followed by blood reinfusion to a MAP of 70 mmHg (hospital period). In vivo two-photon microscopy was used to monitor cerebral microvascular blood flow, tissue hypoxia (NADH), and neuronal necrosis (i.v. propidium iodide) for 5 h after TBI+HS, followed by postmortem DiI vascular painting. Temperature, MAP, blood gases, and electrolytes were monitored. Statistical analyses were done using GraphPad Prism by Student's t-test or Kolmogorov-Smirnov test, where appropriate. TBI+HS compromised mvCBF and tissue oxygen supply due to capillary microthrombosis. HES-DRP improved mvCBF and tissue oxygenation (p < 0.05) better than HES. The number of dead neurons in the HES-DRP was significantly less than in the HES group: 76.1 ± 8.9 vs. 178.5 ± 10.3 per 0.075 mm (P < 0.05). Postmortem visualization of painted vessels revealed vast microthrombosis in both hemispheres that were 33 ± 2% less in HES-DRP vs. HES (p < 0.05). Thus, resuscitation after TBI+HS using HES-DRP effectively restores mvCBF and reduces hypoxia, microthrombosis, and neuronal necrosis compared to HES. HES-DRP is more neuroprotective than lactated Ringer's with DRP and requires an infusion of a smaller volume, which reduces the development of hypervolemia-induced brain edema.
失血性休克(HS)是创伤性脑损伤(TBI)的一种严重并发症,由于低血压导致脑微血管血流(mvCBF)严重受损和氧输送减少,死亡率增加一倍。HS 用复苏液(RF)进行容量扩张不能改善微血管 CBF(mvCBF);此外,它会加重脑水肿。我们发现,向晶状 RF(乳酸林格氏液)中添加减阻聚合物(DRP)可显著改善 TBI+HS 大鼠的 mvCBF、氧供应和神经元存活。在这里,我们比较了胶体 RF(羟乙基淀粉)与 DRP(HES-DRP)和无 DRP(HES)的效果。在大鼠中诱导流体冲击性 TBI(1.5 ATA,50 ms),然后控制 HS 至平均动脉压(MAP)为 40 mmHg。HES 或 HES-DRP 输注以将 MAP 恢复至 60 mmHg 1 小时(院前期),然后再输血至 MAP 为 70 mmHg(医院期)。在 TBI+HS 后 5 小时内使用活体双光子显微镜监测脑微血管血流、组织缺氧(NADH)和神经元坏死(静脉注射碘化丙啶),然后进行死后 DiI 血管染色。监测体温、MAP、血气和电解质。使用 GraphPad Prism 通过 Student's t 检验或 Kolmogorov-Smirnov 检验进行统计分析,视情况而定。TBI+HS 由于毛细血管微血栓形成而导致 mvCBF 和组织氧供应受损。HES-DRP 改善 mvCBF 和组织氧合作用(p <0.05)优于 HES。HES-DRP 组的死亡神经元数量明显少于 HES 组:每 0.075 mm 为 76.1 ± 8.9 个 vs. 178.5 ± 10.3 个(p <0.05)。死后血管染色显示,两个半球均有广泛的微血栓形成,HES-DRP 组比 HES 组少 33 ± 2%(p <0.05)。因此,与 HES 相比,TBI+HS 后使用 HES-DRP 复苏可有效恢复 mvCBF,并减少缺氧、微血栓形成和神经元坏死。与含有 DRP 的乳酸林格氏液相比,HES-DRP 具有更好的神经保护作用,且所需输注体积更小,从而减少了高容量诱导性脑水肿的发生。